Optimizing Pembrolizumab Therapy With Timing and Intensification With Axitinib
Clinical trial NCT05263609 · WITHDRAWN
Trial details
- NCT number
- NCT05263609
- Sponsor
- University of Oklahoma
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2026-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.